Alder BioPharmaceuticals Regains Worldwide Rights To Clazakizumab
September 02, 2014 at 07:04 AM EDT
Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a clinical-stage company developing antibody therapeutics, today announced that it has ...